Jiangsu Lianhuan Pharmaceutical Co., Ltd.
SHH: 600513.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhen Hua Qian
- Employees
- 1,296
- Headquarters
- Yangzhou, China
- IPO year
- 2003
- Market cap
- CN¥6.2B
- Website
- https://www.lhpharma.com
Loading 600513…
Loading profile data…Frequently asked questions about 600513
What does Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) do?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers cardiovascular, anti-allergic, urinary, anti-infective, and immunomodulatory products. The company was founded in 2000 and is headquartered in Yangzhou, China.
Where does 600513.SS trade?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) trades on the Shanghai Stock Exchange.
What sector is 600513.SS in?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jiangsu Lianhuan Pharmaceutical Co., Ltd.?
Zhen Hua Qian is the chief executive officer of Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS).
Where is Jiangsu Lianhuan Pharmaceutical Co., Ltd. headquartered?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. is headquartered in China.
Does 600513.SS pay a dividend?
Yes — Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) paid a trailing twelve-month dividend of CNY 0.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600513.SS go public?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) completed its initial public offering in 2003.